Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Acosta
Ivan F. Acosta, Bogata CO
| Patent application number | Description | Published |
|---|---|---|
| 20120010077 | Methods for Controlling Flower Development in Plants - The present invention provides a method of controlling the sexuality of a plant comprising treating the plant with a composition comprising a compound selected from the group consisting of jasmonic acid, a jasmonic acid derivative, and a salt thereof. | 01-12-2012 |
Javier Salinas Acosta, Rio Bravo MX
| Patent application number | Description | Published |
|---|---|---|
| 20100281467 | METHOD AND APPARATUS FOR AUTOMATIC SOFTWARE TESTING - System and method for automated testing of computer software, especially for business process (enterprise) computer software applications. The present system generates scripts for testing software in an automated manner. Business process testing scripts, for instance for functional automated software testing, are thereby converted by an adapter to other types of testing scripts, for instance for testing performance or security or application monitoring. | 11-04-2010 |
Jorge Berlanga Acosta, Ciudad De La Habana CU
| Patent application number | Description | Published |
|---|---|---|
| 20080312139 | Use of Pharmaceutical Composition Containing Epidermal Growth Factor (EGF) for Diabetic foot Amputation Prevention - The invention relates to the use of Epidermal Growth Factor (EGF) in a preferably-Injectable pharmaceutical composition which is administered by means of infiltration into and around chronic cutaneous ischaemic lesions in order to prevent diabetic foot amputation. Said composition can be administered to recently-created surgical surfaces damaged by the effect of acute reperfusion with oxygenated blood following prolonged ischaemia, thereby preventing further surgical procedures and favouring the preservation of the extremity. The aforementioned composition can be used to improve (i) the cell microenvironment, thereby increasing the reparative and defensive capacity and viability of the is tissues and (ii) the cicatrisation of cutaneous ischaemic lesions, thereby stimulating cell proliferation. The invention is suitable for use in human, veterinary and experimental medicine, specifically in vascular angiology and surgery, dermatology, burn treatment and reconstructive surgery and geriatric medicine. Said composition can be used for recalcitrant ulcers which are associated with lesions in the macro and/or microvasculature, patients with inadequate lymphatic and/or venous return and ulcers or other lesions which are difficult to cicatrise and/or heal. | 12-18-2008 |
| 20090221512 | PHARMACEUTICAL COMPOSITION CONTAINING GHRP-6 TO PREVENT AND ELIMINATE FIBROSIS AND OTHER PATHOLOGICAL DEPOSITS IN TISSUES - The present invention is related to the use of secretagogue peptides repeatedly administered as part of a pharmaceutical composition that prevent and eradicate the deposition of pathological fibrotic material in parenchymal tissues of internal organs like the liver, lungs, esophagus, small intestine, kidneys, blood vessels, joints, and other systemic forms of cutaneous fibrosis of any etiopathogenesis. Additionally, these peptides prevent and eradicate deposition of amiloid and hyaline materials in any of their correspondent chemical forms and tissue manifestations in the brain, cerebellum, blood vessels, liver, intestines, kidneys, spleen, pancreas, joints and the skin, among others. By this way, cellular, tissular and organ dysfunctions generated by these depositions are corrected. The peptides of the present invention are infiltrated or topically applied, contributing to prevent and eradicate keloids and hypertrophic scars in the skin, derived as sequelae of burns and other cutaneous trauma. | 09-03-2009 |
| 20110230415 | Pharmaceutical Composition Containing GHRP-6 To Prevent And Eliminate Fibrosis And Other Pathological Deposits In Tissues - The present invention is related to the use of secretagogue peptides repeatedly administered as part of a pharmaceutical composition that prevent and eradicate the deposition of pathological fibrotic material in parenchymal tissues of internal organs like the liver, lungs, esophagus, small intestine, kidneys, blood vessels, joints, and other systemic forms of cutaneous fibrosis of any etiopathogenesis. Additionally, these peptides prevent and eradicate deposition of amiloid and hyaline materials in any of their correspondent chemical forms and tissue manifestations in the brain, cerebellum, blood vessels, liver, intestines, kidneys, spleen, pancreas, joints and the skin, among others. By this way, cellular, tissular and organ dysfunctions generated by these depositions are corrected. The peptides of the present invention are infiltrated or topically applied, contributing to prevent and eradicate keloids and hypertrophic scars in the skin, derived as sequelae of burns and other cutaneous trauma. | 09-22-2011 |
Jose Angel Acosta, Maracaibo VE
| Patent application number | Description | Published |
|---|---|---|
| 20110020109 | Peripheral Tunnels Propeller - This disclosure is related with propeller noise and cavitation abatement in applications like propulsion, ventilation, pumping or turbine systems on liquid or gas fluids working like a propellers, pumps, fans or turbines, by novel techniques that allows a stronger propellers and improves laminar flow and allow a smooth acceleration or deceleration of the liquid or gas by means of a propeller that consist on a rotating cylindrical block with one or more tunnels around it axis, said cylindrical block also may have flow separators structures at both input and output that helps to keep laminar flow of the fluid or gas with it surrounding media, having This rotating cylindrical block tunnels with either circular or irregular oval section that accelerates fluid or gas by means of both combined centrifugal and axial movement. | 01-27-2011 |
Juan Antonio Torres Acosta, Gent BE
| Patent application number | Description | Published |
|---|---|---|
| 20080207449 | Nucleic Acid Molecules Encoding Plant Cell Cycle Proteins and Uses Therefor - The invention provides isolated nucleic acids molecules, designated CCP nucleic acid molecules, which encode novel cell cycle associated polypeptides. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing CCP, nucleic acid molecules, host cells into which the expression vectors have been introduced, and transgenic plants in which a CCP gene has been introduced or disrupted. The invention still further provides isolated CCP proteins, fusion proteins, antigenic peptides and anti-CCP antibodies. Agricultural, diagnostic, screening, and therapeutic methods utilizing compositions or the invention are also provided. | 08-28-2008 |
Pablo Rodriguez Acosta, San Jose CR
| Patent application number | Description | Published |
|---|---|---|
| 20110314760 | LOAD BEARING WALL FORMWORK SYSTEM AND METHOD - A load bearing wall formwork system and method are disclosed. The load bearing wall formwork system comprises a unique clip assembly for joining two or more substantially planar structures, such as a wall panel, in a spaced apart manner and providing a space there between for placement of a flowable material. The clip assembly comprises a first clip member having a first side for attachment to the wall panel, a second side and an opening positioned between the first and second sides, as well as a second clip member, engageable with the first clip member, having a first side for attachment to a second wall panel, a second side and an opening positioned between the first and second sides. The openings provided in the first and second clip members are aligned when the clip members are engaged. A connecting member is insertable into the aligned openings of the first and second clip members, connecting the first and second clip members together. A wall formed by the foregoing components and a method of assembling a wall formwork are also disclosed. | 12-29-2011 |